CHENG; Peter T.W.

Patent Applications and Registrations

Patent applications and USPTO patent grants for CHENG; Peter T.W..The latest application filed is for "glucokinase activators and methods of using same".

Company Profile

2.22.23

CHENG; Peter T.W. - Princeton NJ
Cheng; Peter T.W. - Pennington NJ
Cheng; Peter T. W. - Lawrenceville NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Glucokinase Activators And Methods Of Using Same App 20190233449 - CHENG; Peter T.W. ; et al.	2019-08-01
Phenyl-(aza)cycloalkyl carboxylic acid GPR120 modulators Grant 10,336,684 - Cheng , et al.	2019-07-02
Phenyl-(aza)cycloalkyl Carboxylic Acid Gpr120 Modulators App 20180319737 - CHENG; PETER T. W. ; et al.	2018-11-08
Cyclobutane containing carboxylic acid GPR120 modulators Grant 10,023,519 - Shi , et al. July 17, 2	2018-07-17
Cyclopropanecarboxylic acid GPR120 modulators Grant 9,938,222 - Shi , et al. April 10, 2	2018-04-10
Phenyl-(aza)cycloalkyl Carboxylic Acid Gpr120 Modulators App 20170327457 - Cheng; Peter T.W. ; et al.	2017-11-16
Cyclopropanecarboxylic Acid Gpr120 Modulators App 20170253554 - Shi; Yan ; et al.	2017-09-07
Cyclobutane Containing Carboxylic Acid Gpr120 Modulators App 20170247311 - Shi; Yan ; et al.	2017-08-31
Bicyclo [2.2.1] acid GPR120 modulators Grant 9,518,000 - Shi , et al. December 13, 2	2016-12-13
Bicyclo [2.2.2] Acid Gpr120 Modulators App 20160039780 - Shi; Yan ; et al.	2016-02-11
Bicyclo [2.2.1] Acid Gpr120 Modulators App 20160016880 - Shi; Yan ; et al.	2016-01-21
Oxabicyclo [2.2.2] acid GPR120 modulators Grant 8,962,660 - Zhang , et al. February 24, 2	2015-02-24
Oxabicyclo [2.2.2] Acid Gpr120 Modulators App 20140275173 - Zhang; Hao ; et al.	2014-09-18
Substituted pyrazolylamides useful as glucokinase activators Grant 8,614,332 - Ryono , et al. December 24, 2	2013-12-24
Glucokinase activators and methods of using same Grant 8,592,396 - Meng , et al. November 26, 2	2013-11-26
Novel Glucokinase Activators And Methods Of Using Same App 20130029939 - Meng; Wei ; et al.	2013-01-31
Glucokinase activators and methods of using same Grant 8,273,777 - Shi , et al. September 25, 2	2012-09-25
1,3-dihydroxy substituted phenylamide glucokinase activators Grant 8,222,285 - Chen , et al. July 17, 2	2012-07-17
Novel Glucokinase Activators And Methods Of Using Same App 20120142636 - Ryono; Denis E. ; et al.	2012-06-07
Substituted pyrazolylamide compounds useful as glucokinase activators Grant 8,153,677 - Ryono , et al. April 10, 2	2012-04-10
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method Grant 7,951,793 - Cheng , et al. May 31, 2	2011-05-31
Novel Glucokinase Activators And Methods Of Using Same App 20110118211 - Ryono; Denis E. ; et al.	2011-05-19
Phosphonate and phosphinate pyrazolylamide glucokinase activators Grant 7,910,747 - Ryono , et al. March 22, 2	2011-03-22
Glucokinase activators and methods of using same Grant 7,888,504 - Chen , et al. February 15, 2	2011-02-15
Novel Glucokinase Activators And Methods Of Using Same App 20100324071 - Shi; Yan ; et al.	2010-12-23
Glucokinase activators and methods of using same Grant 7,812,048 - Shi , et al. October 12, 2	2010-10-12
Substituted acid derivatives useful as anti-atherosclerotic, anti-dyslipidemic, anti-diabetic and anti-obesity agents and method Grant 7,795,291 - Tino , et al. September 14, 2	2010-09-14
1,3-dihydroxy Substituted Phenylamide Glucokinase Activators App 20100179121 - Chen; Sean ; et al.	2010-07-15
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method Grant 7,507,757 - Cheng , et al. March 24, 2	2009-03-24
Novel Glucokinase Activators And Methods Of Using Same App 20090030046 - Shi; Yan ; et al.	2009-01-29
Novel Glucokinase Activators And Methods Of Using Same App 20080021052 - Chen; Sean ; et al.	2008-01-24
Novel Glucokinase Activators And Methods Of Using Same App 20080009465 - Ryono; Denis E. ; et al.	2008-01-10
Substituted Acid Derivatives Useful As Anti-atherosclerotic, Anti-dyslipidemic, Anti-diabetic And Anti-obesity Agents And Method App 20080009533 - Tino; Joseph A. ; et al.	2008-01-10
Substituted Acid Derivatives Useful As Antidiabetic And Antiobesity Agents And Method App 20080009534 - Cheng; Peter T.W. ; et al.	2008-01-10
Substituted Heterocyclic Derivatives Useful As Antidiabetic And Antiobesity Agents And Method App 20070287713 - Cheng; Peter T. W. ; et al.	2007-12-13
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method Grant 7,279,485 - Cheng , et al. October 9, 2	2007-10-09
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method App 20050119312 - Cheng, Peter T.W. ; et al.	2005-06-02
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method Grant 6,875,782 - Cheng , et al. April 5, 2	2005-04-05
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method App 20040063762 - Cheng, Peter T. W. ; et al.	2004-04-01
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method App 20040063700 - Cheng, Peter T.W. ; et al.	2004-04-01
Catecholamine surrogates useful as .beta..sub.3 agonists Grant 5,770,615 - Cheng , et al. June 23, 1	1998-06-23
Prodrug esters of phosphonosulfonate squalene synthetase inhibitors and method Grant 5,618,964 - Cheng , et al. April 8, 1	1997-04-08

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.